Publication:
Cost Effectiveness of Rivaroxaban for Stroke Prevention in Atrial Fibrillation Patients for TTR and CHADS2 Score in Lithuania

dc.contributor.authorKockaya, G.
dc.contributor.authorAidietiene, S.
dc.contributor.authorErgin, Oguzhan G.
dc.contributor.authorOkcun, S.
dc.contributor.authorKurnaz, M.
dc.date.accessioned2025-12-11T00:22:30Z
dc.date.issued2019
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Kockaya, G.] ECONiX, Ankara, Turkey; [Aidietiene, S.] Vilnius Univ, Vilnius, Lithuania; [Ergin, Oguzhan G.] 19 Mayis Univ, Samsun, Turkey; [Okcun, S.; Kurnaz, M.] ECONiX, Istanbul, Turkeyen_US
dc.description.woscitationindexScience Citation Index Expanded - Social Science Citation Index
dc.identifier.endpageS559en_US
dc.identifier.issn1098-3015
dc.identifier.issn1524-4733
dc.identifier.scopusqualityQ1
dc.identifier.startpageS558en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/36216
dc.identifier.volume22en_US
dc.identifier.wosWOS:000503167001100
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofValue in Healthen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleCost Effectiveness of Rivaroxaban for Stroke Prevention in Atrial Fibrillation Patients for TTR and CHADS2 Score in Lithuaniaen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files